BBOTVSLABT• 28 Days (Normalized)
BBOT vs LABT (BridgeBio Oncology Therapeutics Inc. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Sep 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-56.68%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
LABT Performance $0.93
-50.39%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin LABT LEADS
-6.29 pts
LABT outperforming by 6.29 percentage points
BBOTLABT
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | BBOT Price | BBOT Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -56.68% | $0.93 | -50.39% | -6.29% |
| Sep 30, 2026 | $4.10 | -54.34% | $- | - | |
| Sep 29, 2026 | $3.92 | -56.35% | $0.99 | -47.34% | -9.01% |
| Sep 28, 2026 | $3.81 | -57.57% | $1.15 | -38.83% | -18.74% |
| Sep 25, 2026 | $3.95 | -56.01% | $1.67 | -11.17% | -44.84% |
| Sep 24, 2026 | $3.99 | -55.57% | $1.83 | -2.66% | -52.91% |
| Sep 23, 2026 | $4.16 | -53.67% | $1.78 | -5.32% | -48.35% |
| Sep 22, 2026 | $4.66 | -48.11% | $1.99 | +5.85% | -53.96% |
| Sep 21, 2026 | $4.66 | -48.11% | $2.05 | +9.04% | -57.15% |
| Sep 18, 2026 | $4.77 | -46.88% | $1.99 | +5.85% | -52.73% |
| Sep 17, 2026 | $4.89 | -45.55% | $1.86 | -1.06% | -44.49% |
| Sep 16, 2026 | $4.76 | -46.99% | $2.09 | +11.17% | -58.16% |
| Sep 15, 2026 | $4.88 | -45.66% | $2.17 | +15.43% | -61.09% |
| Sep 14, 2026 | $5.05 | -43.76% | $2.12 | +12.77% | -56.53% |
| Sep 11, 2026 | $4.95 | -44.88% | $2.22 | +18.09% | -62.97% |
Page 1 of 2